Calida stock is in focus today after results and fresh capital plans. The group reported EBIT doubling to CHF 9 million despite a 6.6% revenue decline, with Calida earnings 2026 released on 26 February. Management announced a Calida share buyback of up to 2% from 9 March and trimmed the dividend to CHF 0.25. As of today, CALN.SW trades at CHF 12.90, up 0.16%, with a day range of CHF 12.46 to CHF 13.00. We see catalysts in margin progress, portfolio actions, and disciplined capital returns for Swiss investors.

Results and guidance after February 26

Calida reported EBIT of CHF 9 million, up sharply as cost and mix improvements offset softer demand. Revenue fell 6.6%, but profitability improved on pricing, inventory discipline, and lower overheads. Management framed the improvement as a step toward a >6% EBIT-margin target. Swiss media noted the profit focus despite weaker sales in core markets source.

The board launched a Calida share buyback of up to 2% starting 9 March, while cutting the dividend to CHF 0.25 per share. With 6.99 million shares outstanding, the buyback implies roughly 140,000 shares and about CHF 1.8 million at today’s price. The dividend reset preserves cash for growth and restructuring source.

Strategy: premium focus and Cosabella

Management doubled down on premium segments, aiming to lift group EBIT margin above 6%. The path includes tighter assortments, price discipline, and lower discounts, while reducing complexity across brands. Progress rests on stabilising demand in DACH and France, keeping inventories lean, and holding fixed costs flat. Execution through 2026 is the key proof point for Calida stock.

Cosabella remains under review after underperformance. Options could include a sale, partnership, or deeper restructuring. Any move that cuts losses or frees capital would support margin expansion. Investors should watch for an update alongside the buyback start in March, as portfolio actions can quickly change group mix and returns.

Valuation and balance sheet

At CHF 12.90, Calida stock trades at 0.72x price-to-book, 0.40x price-to-sales, and 7.87x EV/EBITDA. The negative PE is not informative given recent losses. Leverage looks moderate with net debt to EBITDA at 1.37x and interest coverage at 6.79x. These metrics suggest upside if margins keep improving in 2026.

Free cash flow per share is CHF 3.14 on the latest run-rate, providing room for selective returns. The CHF 0.25 dividend implies about CHF 1.75 million cash out, while a 2% buyback would be near CHF 1.8 million at current prices. The mix balances investor payouts with financial flexibility for restructuring and brand investment.

Technical view and Swiss trading context

Technical signals tilt bullish short term. RSI is 63.43, MACD is above its signal, and MFI at 77.16 aligns with strong buying. CCI at 161 suggests overbought, while ADX at 16.88 indicates no strong trend yet. Price sits above the Bollinger upper band of CHF 12.83, calling for patience on entries.

Price is CHF 12.90 with a day range of CHF 12.46 to CHF 13.00. Liquidity improved, with 14,193 shares traded versus an average of 8,395. Watch the 50-day average at CHF 12.11 and the middle Bollinger band at CHF 12.18 as support. The 200-day average at CHF 13.87 is notable resistance for CALN.SW.

Final Thoughts

Calida stock now mixes improving margins with clearer capital returns. EBIT doubled to CHF 9 million despite lower sales, the dividend reset to CHF 0.25 protects cash, and a 2% buyback from 9 March signals confidence. The premium focus and a >6% EBIT-margin goal frame 2026 execution, while the Cosabella review could unlock value or reduce losses. Valuation is undemanding on book and sales, and leverage is manageable. Tactically, momentum is firm but overbought, so pullbacks toward CHF 12.20 to CHF 12.50 may offer cleaner risk levels, while CHF 13.87 is the resistance to watch. Meyka’s system grade is C+ with a Hold stance. Position size prudently and monitor margin milestones and portfolio news.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.